Mojtaba Noursalehi

1.4k total citations
18 papers, 850 citations indexed

About

Mojtaba Noursalehi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Mojtaba Noursalehi has authored 18 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Genetics. Recurrent topics in Mojtaba Noursalehi's work include Neurogenetic and Muscular Disorders Research (5 papers), Muscle Physiology and Disorders (4 papers) and Cancer Treatment and Pharmacology (3 papers). Mojtaba Noursalehi is often cited by papers focused on Neurogenetic and Muscular Disorders Research (5 papers), Muscle Physiology and Disorders (4 papers) and Cancer Treatment and Pharmacology (3 papers). Mojtaba Noursalehi collaborates with scholars based in United States, France and Germany. Mojtaba Noursalehi's co-authors include Stephen J. DeMichele, Eric R. Pacht, James E. Gadek, Jeffrey L. Nelson, Michael D. Karlstad, Timothy E. Albertson, Ann K. Wennberg, Michael P. Donahoe, Jean-Christophe Eymard and Nicholas D. James and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Critical Care Medicine.

In The Last Decade

Mojtaba Noursalehi

18 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mojtaba Noursalehi United States 7 499 372 176 149 124 18 850
Andrea U. Steinbicker Germany 17 95 0.2× 251 0.7× 139 0.8× 22 0.1× 139 1.1× 67 1.1k
Sylvie Bélanger Canada 15 334 0.7× 104 0.3× 29 0.2× 85 0.6× 238 1.9× 19 771
Mariele Dessì Italy 13 153 0.3× 123 0.3× 431 2.4× 311 2.1× 239 1.9× 34 1.1k
Ke Jiang China 14 51 0.1× 70 0.2× 85 0.5× 116 0.8× 118 1.0× 32 608
Huihui Li China 16 84 0.2× 55 0.1× 96 0.5× 90 0.6× 164 1.3× 38 683
Jerome L. Sullivan United States 15 146 0.3× 241 0.6× 92 0.5× 27 0.2× 129 1.0× 28 937
Oliver Tiebel Germany 12 65 0.1× 131 0.4× 92 0.5× 45 0.3× 107 0.9× 36 741
Paul Hollington Australia 15 306 0.6× 89 0.2× 101 0.6× 199 1.3× 220 1.8× 33 953
Miho Hida Japan 12 236 0.5× 68 0.2× 205 1.2× 115 0.8× 214 1.7× 39 850
Soichiro Tajima Japan 15 136 0.3× 107 0.3× 84 0.5× 66 0.4× 118 1.0× 27 688

Countries citing papers authored by Mojtaba Noursalehi

Since Specialization
Citations

This map shows the geographic impact of Mojtaba Noursalehi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mojtaba Noursalehi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mojtaba Noursalehi more than expected).

Fields of papers citing papers by Mojtaba Noursalehi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mojtaba Noursalehi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mojtaba Noursalehi. The network helps show where Mojtaba Noursalehi may publish in the future.

Co-authorship network of co-authors of Mojtaba Noursalehi

This figure shows the co-authorship network connecting the top 25 collaborators of Mojtaba Noursalehi. A scholar is included among the top collaborators of Mojtaba Noursalehi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mojtaba Noursalehi. Mojtaba Noursalehi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shieh, Perry B., Nancy L. Kuntz, James J. Dowling, et al.. (2022). OP018: ASPIRO gene therapy trial in X-Linked Myotubular Myopathy (XLMTM): Update on preliminary efficacy and safety findings. Genetics in Medicine. 24(3). S350–S350. 6 indexed citations
2.
Shieh, Perry B., James J. Dowling, Wolfgang Müller‐Felber, et al.. (2021). CLINICAL TRIAL HIGHLIGHTS. Neuromuscular Disorders. 31. S47–S47. 1 indexed citations
3.
Blaschek, Astrid, Perry B. Shieh, Nancy L. Kuntz, et al.. (2021). ASPIRO Gene Therapy Trial in X-Linked Myotubular Myopathy (XLMTM): Update on Preliminary Efficacy and Safety Findings. Neuropediatrics. 1 indexed citations
4.
Duong, Tina, Gale Harding, Sally Mannix, et al.. (2020). Use of the Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) in X-Linked Myotubular Myopathy: Content Validity and Psychometric Performance. Journal of Neuromuscular Diseases. 8(1). 63–77. 7 indexed citations
5.
Graham, Robert J., Francesco Muntoni, Imelda Hughes, et al.. (2019). Mortality and respiratory support in X-linked myotubular myopathy: a RECENSUS retrospective analysis. Archives of Disease in Childhood. 105(4). 332–338. 25 indexed citations
6.
Servais, Laurent, Perry B. Shieh, James J. Dowling, et al.. (2019). P.105INCEPTUS pre-phase 1, prospective, non-interventional, natural history run-in study to evaluate subjects aged 4 years and younger with X-linked myotubular myopathy (XLMTM). Neuromuscular Disorders. 29. S79–S79. 1 indexed citations
7.
Dowling, James J., Perry B. Shieh, Nancy L. Kuntz, et al.. (2019). O.39ASPIRO phase 1/2 gene therapy trial in X-linked motubular myopathy (XLMTM): update on preliminary safety and efficacy findings. Neuromuscular Disorders. 29. S207–S207. 2 indexed citations
8.
Kuntz, Nancy L., Perry B. Shieh, Barbara K. Smith, et al.. (2018). NEW THERAPEUTIC APPROACHES AND THEIR READOUT. Neuromuscular Disorders. 28. S91–S91. 6 indexed citations
9.
Mahadevan, Daruka, Geoffrey I. Shapiro, Sandra Kurtin, et al.. (2013). Activity of AT13387, a novel, non-ansamycin inhibitor of heat shock protein 90, against gastrointestinal stromal tumors (GIST).. Journal of Clinical Oncology. 31(4_suppl). 105–105. 6 indexed citations
10.
11.
Byers, Lauren A., Leora Horn, Goetz Kloecker, et al.. (2013). Abstract 2095: A phase 2 study of Amuvatinib (MP-470), the first RAD51 inhibitor in combination with platinum-etoposide (PE) in refractory or relapsed small cell lung cancer (ESCAPE).. Cancer Research. 73(8_Supplement). 2095–2095. 3 indexed citations
12.
Sternberg, Cora N., Daniel P. Petrylak, Oliver Sartor, et al.. (2009). Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial. Journal of Clinical Oncology. 27(32). 5431–5438. 262 indexed citations
13.
Sartor, Oliver, Daniel P. Petrylak, C. Sternberg, et al.. (2009). Use of pain at baseline and pain progression to predict overall survival (OS) in patients (pts) with docetaxel pretreated metastatic castration-refractory prostate cancer (CRPC): Results from the SPARC trial. Journal of Clinical Oncology. 27(15_suppl). 5148–5148. 1 indexed citations
14.
Shabsigh, Ridwan, Richard Sadovsky, R. Rosen, et al.. (2008). Impact of an educational initiative on applied knowledge and attitudes of physicians who treat sexual dysfunction. International Journal of Impotence Research. 21(1). 74–81. 10 indexed citations
15.
Thompson, Dana S., David R. Spigel, John D. Hainsworth, et al.. (2008). Phase II trial of satraplatin (S) and paclitaxel (P) in first-line advanced non-small cell lung cancer (NSCLC) treatment: Final results. Journal of Clinical Oncology. 26(15_suppl). 19023–19023. 3 indexed citations
16.
Gadek, James E., Stephen J. DeMichele, Michael D. Karlstad, et al.. (1999). Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine. 27(8). 1409–1420. 485 indexed citations
17.
Palombo, John D., et al.. (1998). Metabolism of dietary α‐linolenic acid vs. eicosapentaenoic acid in rat immune cell phospholipids during endotoxemia. Lipids. 33(11). 1099–1105. 19 indexed citations
18.
Gadek, James E., Michael D. Karlstad, Michael J. Murray, et al.. (1998). Enteral nutrition with eicosapentaenoic acid (EPA), γ-linolenic acid (GLA) and antioxidants reduces pulmonary inflammation and new organ failures in patients with Acute Respiratory Distress Syndrome (ARDS). 114. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea U. Steinbicker Breakdown of academic impact, for papers by Sylvie Bélanger Breakdown of academic impact, for papers by Mariele Dessì Breakdown of academic impact, for papers by Ke Jiang Breakdown of academic impact, for papers by Huihui Li Breakdown of academic impact, for papers by Jerome L. Sullivan Breakdown of academic impact, for papers by Oliver Tiebel Breakdown of academic impact, for papers by Paul Hollington Breakdown of academic impact, for papers by Miho Hida Breakdown of academic impact, for papers by Soichiro Tajima
Rankless by CCL
2026